Showing results (11-20 of 122) with videos related to
Sort By:
Pageof 13
Therapeutic Advances in Hematology|October 2, 2015
CD19-redirected chimeric antigen receptor-modified T cells: a promising immunotherapy for children and adults with B-cell acute lymphoblastic leukemia (ALL)Sarah K Tasian, Rebecca A GardnerFrontiers in Pediatrics|December 7, 2017
Targeting FLT3 Signaling in Childhood Acute Myeloid LeukemiaAmy N Sexauer, Sarah K TasianBest Practice & Research. Clinical Haematology|December 6, 2021
Has Ph-like ALL Superseded Ph+ ALL as the Least Favorable Subtype?Thai Hoa Tran, Sarah K TasianBritish Journal of Haematology|December 17, 2016
Genomic characterization of paediatric acute lymphoblastic leukaemia: an opportunity for precision medicine therapeuticsSarah K Tasian, Stephen P HungerCurrent Opinion in Pediatrics|December 19, 2019
The future of cellular immunotherapy for childhood leukemiaChallice L Bonifant, Sarah K TasianBiomedicines|February 22, 2018
Targeting Leukemia Stem Cells in the Bone Marrow NicheSarah K Tasian, Martin Bornhäuser, Sergio RutellaBest Practice & Research. Clinical Haematology|October 21, 2017
How is the Ph-like signature being incorporated into ALL therapy?Luke Maese, Sarah K Tasian, Elizabeth A RaetzFrontiers in Oncology|March 28, 2014
Molecular therapeutic approaches for pediatric acute myeloid leukemiaSarah K Tasian, Jessica A Pollard, Richard AplencBlood|October 4, 2017
Philadelphia chromosome-like acute lymphoblastic leukemiaSarah K Tasian, Mignon L Loh, Stephen P HungerFrontiers in Oncology|June 7, 2014
Targeting the PI3K/mTOR Pathway in Pediatric Hematologic MalignanciesSarah K Tasian, David T Teachey, Susan R RheingoldPageof 13